Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-19-000169
Filing Date
2019-11-12
Accepted
2019-11-12 06:31:49
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20190930.htm   iXBRL 10-Q 1538640
2 EXHIBIT 31.1 a2019q3ex311-xnextgen.htm EX-31.1 12203
3 EXHIBIT 31.2 a2019q3ex312-xnextgen.htm EX-31.2 11921
4 EXHIBIT 32.1 a2019q3ex321-xnextgen.htm EX-32.1 7037
5 EXHIBIT 32.2 a2019q3ex322-xnextgen.htm EX-32.2 7139
11 mbx-20190930_g1.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000169.txt   6870233

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbx-20190930.xsd EX-101.SCH 45103
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbx-20190930_cal.xml EX-101.CAL 60540
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbx-20190930_def.xml EX-101.DEF 193935
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbx-20190930_lab.xml EX-101.LAB 540410
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbx-20190930_pre.xml EX-101.PRE 338543
35 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20190930_htm.xml XML 1133087
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 191205906
SIC: 2834 Pharmaceutical Preparations